STAT3 and lung carcinoma: In lung cancer, the N-myristoylation of enhancer of zeste homolog 2 (EZH2) facilitates the formation of LLPS droplets that concentrate the substrate signal transducer and transcription 3 (STAT3) activator, thereby increasing STAT3 signaling and driving cell proliferation [180](Fig. 4).